{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:19:47Z","timestamp":1792441187433,"version":"4.5.0"},"reference-count":73,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T00:00:00Z","timestamp":1707436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>The majority of patients requiring heart valve replacement in low- to middle-income countries (LMICs) need it for rheumatic heart disease (RHD). While the young age of such patients largely prescribes replacement with mechanical prostheses, reliable anticoagulation management is often unattainable under the prevailing socioeconomic circumstances. Cases of patients with clotted valves presenting for emergency surgery as a consequence of poor adherence to anticoagulation control are frequent. The operative mortality rates of reoperations for thrombosed mechanical valves are several times higher than those for tissue valves, and long-term results are also disappointing. Under-anticoagulation prevails in these regions that has clearly been linked to poor international normalised ratio (INR) monitoring. In industrialised countries, safe anticoagulation is defined as &amp;gt;60%\u201370% of the time in the therapeutic range (TTR). In LMICs, the TTR has been found to be in the range of twenty to forty percent. In this study, we analysed &amp;gt;20,000 INR test results of 552 consecutive patients receiving a mechanical valve for RHD. Only 27% of these test results were in the therapeutic range, with the vast majority (61%) being sub-therapeutic. Interestingly, the post-operative frequency of INR tests of one every 3\u20134 weeks in year 1 had dropped to less than 1 per year by year 7. LMICs need to use clinical judgement and assess the probability of insufficient INR monitoring prior to uncritically applying Western guidelines predominantly based on chronological age. The process of identification of high-risk subgroups in terms of non-adherence to anticoagulation control should take into account both the adherence history of &amp;gt;50% of patients with RHD who were in chronic atrial fibrillation prior to surgery as well as geographic and socioeconomic circumstances.<\/jats:p>","DOI":"10.3389\/fcvm.2024.1347838","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T00:04:03Z","timestamp":1707437043000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Mechanical valve replacement for patients with rheumatic heart disease: the reality of INR control in Africa and beyond"],"prefix":"10.3389","volume":"11","author":[{"given":"Peter","family":"Zilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Human","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Pennel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,2,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1055\/s-0043-1769597","article-title":"German Heart Surgery Report 2022: the annual updated registry of the German Society for Thoracic and Cardiovascular Surgery","volume":"71","author":"Beckmann","year":"2023","journal-title":"Thorac Cardiovasc Surg"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1056\/NEJMoa1603693","article-title":"Global, regional, and national burden of rheumatic heart disease, 1990\u20122015","volume":"377","author":"Watkins","year":"2017","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1234165","DOI":"10.3389\/fcvm.2023.1234165","article-title":"Transcatheter heart valve interventions for patients with rheumatic heart disease","volume":"10","author":"Weich","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ijcard.2020.05.073","article-title":"Poorly suited heart valve prostheses heighten the plight of patients with rheumatic heart disease","volume":"318","author":"Scherman","year":"2020","journal-title":"Int J Cardiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/s0022-5223(00)70217-0","article-title":"Mitral valve repair and replacement for rheumatic disease","volume":"119","author":"Yau","year":"2000","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B7","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1177\/2150135112474024","article-title":"Improved long-term survival for rheumatic mitral valve repair compared to replacement in the young","volume":"4","author":"Remenyi","year":"2013","journal-title":"World J Pediatr Congenit Heart Surg"},{"key":"B8","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.gheart.2018.08.002","article-title":"Global unmet needs in cardiac surgery","volume":"13","author":"Zilla","year":"2018","journal-title":"Glob Heart"},{"key":"B9","doi-asserted-by":"publisher","first-page":"336","DOI":"10.21037\/cdt.2019.11.03","article-title":"A glimpse of hope: cardiac surgery in low- and middle-income countries (LMICS)","volume":"10","author":"Zilla","year":"2020","journal-title":"Cardiovasc Diagn Ther"},{"key":"B10","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"43","author":"Vahanian","year":"2022","journal-title":"Eur Heart J"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1001\/jama.2015.3164","article-title":"Survival and outcomes following bioprosthetic vs mechanical mitral valve replacement in patients aged 50 to 69 years","volume":"313","author":"Chikwe","year":"2015","journal-title":"JAMA"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1016\/j.jacc.2022.08.787","article-title":"National trends in TAVR and SAVR for patients with severe isolated aortic stenosis","volume":"80","author":"Sharma","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.17159\/2078-5151\/2022\/v60n1a3192","article-title":"A South Africa tertiary centre experience with redo mitral valve replacement","volume":"60","author":"Kistan","year":"2022","journal-title":"S Afr J Surg"},{"key":"B14","first-page":"123","article-title":"Analysis of the early results of 693 patients undergoing valvular reoperation between 1993 and 2011","volume":"25","author":"Erdem Toker","year":"2016","journal-title":"J Heart Valve Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1016\/j.jtcvs.2014.02.006","article-title":"Short- and long-term outcomes after valve replacement surgery for rheumatic heart disease in the south pacific, conducted by a fly-in\/fly-out humanitarian surgical team: a 20-year retrospective study for the years 1991 to 2011","volume":"148","author":"Thomson Mangnall","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B16","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1055\/s-0038-1666873","article-title":"Mechanical heart valve replacement in a low-middle income region in the modern era: midterm results from a Sub-Saharan center","volume":"68","author":"Mve Mvondo","year":"2020","journal-title":"Thorac Cardiovasc Surg"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1161\/01.cir.99.20.2669","article-title":"Long-term survival and valve-related complications in young women with cardiac valve replacements","volume":"99","author":"North","year":"1999","journal-title":"Circulation"},{"key":"B18","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S0022-5223(19)36936-3","article-title":"Valve replacement in the young patient with rheumatic heart disease. Review of a twenty-year experience","volume":"99","author":"John","year":"1990","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B19","first-page":"54","article-title":"Optimal PT-INR after prosthetic valve replacement: Queen Sirikit Heart Centre\u2019s experience","volume":"31","author":"Taksinachanekij","year":"2010","journal-title":"Thai J Surg"},{"key":"B20","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1080\/20786190.2018.1467182","article-title":"Optimum INR intensity and therapeutic INR controlin patients with mechanical heart valve prosthesis on warfarin oral anticoagulation at Dr. George Mukhari academic hospital: a three year retrospective study","volume":"60","author":"Ntlokozi","year":"2018","journal-title":"S Afr Fam Pract (2004)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1136\/heartasia-2016-010751","article-title":"Predictors of warfarin non-adherence in younger adults after valve replacement surgery in the south pacific","volume":"8","author":"Thomson Mangnall","year":"2016","journal-title":"Heart Asia"},{"key":"B22","doi-asserted-by":"publisher","first-page":"158","DOI":"10.5603\/CJ.a2013.0085","article-title":"Epidemiology, anticoagulant treatment and risk of thromboembolism in patients with valvular atrial fibrillation: results from atrial fibrillation in Turkey: epidemiologic registry (after)","volume":"21","author":"Kaya","year":"2014","journal-title":"Cardiol J"},{"key":"B23","doi-asserted-by":"publisher","first-page":"316","DOI":"10.5830\/CVJA-2019-024","article-title":"Factors associated with sub-optimal control of anticoagulation in patients with prosthetic heart valves taking oral anticoagulants in a Sub-Saharan African setting","volume":"30","author":"Chalachew","year":"2019","journal-title":"Cardiovasc J Afr"},{"key":"B24","doi-asserted-by":"publisher","first-page":"354","DOI":"10.4314\/eamj.v77i7.46667","article-title":"Pattern of anticoagulation control after heart valve surgery at the Kenyatta National Hospital, Nairobi","volume":"77","author":"Ogendo","year":"2000","journal-title":"East Afr Med J"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1161\/CIRCULATIONAHA.116.024769","article-title":"Clinical outcomes in 3343 children and adults with rheumatic heart disease from 14 low- and middle-income countries: two-year follow-up of the Global Rheumatic Heart Disease Registry (the remedy study)","volume":"134","author":"Zuhlke","year":"2016","journal-title":"Circulation"},{"key":"B26","doi-asserted-by":"publisher","first-page":"62","DOI":"10.5334\/gh.1260","article-title":"Clinical profile and outcomes of rheumatic heart disease patients undergoing surgical valve procedures in Uganda","volume":"18","author":"Rwebembera","year":"2023","journal-title":"Glob Heart"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjgh-2023-011763","article-title":"Surgery for rheumatic heart disease in the northern territory, Australia, 1997\u20132016: what have we gained?","volume":"8","author":"Doran","year":"2023","journal-title":"BMJ Glob Health"},{"key":"B28","first-page":"341","article-title":"Simultaneous aortic and mitral valve replacement in children: time-related outcomes and risk factors","volume":"19","author":"Alsoufi","year":"2010","journal-title":"J Heart Valve Dis"},{"key":"B29","doi-asserted-by":"publisher","first-page":"605353","DOI":"10.3389\/fphar.2020.605353","article-title":"Anticoagulation quality of warfarin and the role of physician\u2012pharmacist collaborative clinics in the treatment of patients receiving warfarin: a retrospective, observational, single-center study","volume":"11","author":"Qiu","year":"2020","journal-title":"Front Pharmacol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1186\/s12913-017-2330-0","article-title":"Quality of anticoagulation management with warfarin among outpatients in a tertiary hospital in Addis Ababa, Ethiopia: a retrospective cross-sectional study","volume":"17","author":"Fenta","year":"2017","journal-title":"BMC Health Serv Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12872-019-1078-3","article-title":"Optimal INR level for warfarin therapy after mechanical mitral valve replacement","volume":"19","author":"Kamthornthanakarn","year":"2019","journal-title":"BMC Cardiovasc Disord"},{"key":"B32","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1161\/CIRCOUTCOMES.108.796185","article-title":"Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review","volume":"1","author":"Wan","year":"2008","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"B33","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.11.007","article-title":"Knowledge regarding oral anticoagulation therapy among patients with stroke and those at high risk of thromboembolic events","volume":"24","author":"Alphonsa","year":"2015","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1161\/CIRCULATIONAHA.113.005451","article-title":"Variations in cause and management of atrial fibrillation in a prospective registry of 15,400 emergency department patients in 46 countries: the RE-LY atrial fibrillation registry","volume":"129","author":"Oldgren","year":"2014","journal-title":"Circulation"},{"key":"B35","volume-title":"A 10-Year Institutional Review of Surgery for Structural Valve Dysfunction in the Developing World","author":"Chen","year":"2017"},{"key":"B36","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1001\/archinte.167.3.229","article-title":"The influence of patient adherence on anticoagulation control with warfarin: results from the international normalized ratio adherence and genetics (in-range) study","volume":"167","author":"Kimmel","year":"2007","journal-title":"Arch Intern Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e202026","DOI":"10.21542\/gcsp.2020.26","article-title":"Raising awareness for rheumatic mitral valve disease","volume":"2","author":"Passos","year":"2020","journal-title":"Glob Cardiol Sci Pract"},{"key":"B38","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ijcard.2016.11.070","article-title":"The burden and implications of preoperative atrial fibrillation in Australian Heart Valve Surgery patients","volume":"227","author":"Russell","year":"2017","journal-title":"Int J Cardiol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e016980","DOI":"10.1136\/bmjopen-2017-016980","article-title":"Time in therapeutic range and stability over time for warfarin users in clinical practice: a retrospective cohort study using linked routinely collected health data in Alberta, Canada","volume":"8","author":"McAlister","year":"2018","journal-title":"BMJ Open"},{"key":"B40","doi-asserted-by":"publisher","first-page":"490","DOI":"10.7196\/SAMJ.2018.v108i6.13062","article-title":"Poor anticoagulation control in patients taking warfarin at a tertiary and district-level prothrombin clinic in Cape Town, South Africa","volume":"108","author":"Ebrahim","year":"2018","journal-title":"S Afr Med J"},{"key":"B41","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1023\/B:THRO.0000011377.78585.63","article-title":"Quality assessment of anticoagulation dose management: comparative evaluation of measures of time-in-therapeutic range","volume":"15","author":"Schmitt","year":"2003","journal-title":"J Thromb Thrombolysis"},{"key":"B42","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jsps.2015.02.005","article-title":"Patient adherence to warfarin therapy and its impact on anticoagulation control","volume":"24","author":"Mayet","year":"2016","journal-title":"Saudi Pharm J"},{"key":"B43","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1182\/blood-2009-02-207928","article-title":"Outcomes and predictors of very stable INR control during chronic anticoagulation therapy","volume":"114","author":"Witt","year":"2009","journal-title":"Blood"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.jtcvs.2014.01.004","article-title":"Reduced anticoagulation after mechanical aortic valve replacement: interim results from the prospective randomized on-X valve anticoagulation clinical trial randomized food and drug administration investigational device exemption trial","volume":"147","author":"Puskas","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B45","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1177\/0267659118817712","article-title":"Impact of prosthetic heart valves on pregnancy in Bangladeshi women","volume":"34","author":"Ranjan","year":"2019","journal-title":"Perfusion"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.rec.2017.02.041","article-title":"Real structural valve deterioration of the mitroflow aortic prosthesis: competing risk analysis","volume":"70","author":"Diaz","year":"2017","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"B47","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.biomaterials.2007.09.033","article-title":"Prosthetic heart valves: catering for the few","volume":"29","author":"Zilla","year":"2008","journal-title":"Biomaterials"},{"key":"B48","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/S0022-5223(19)41185-9","article-title":"Replacement of prosthetic heart valves. A fifteen-year experience","volume":"74","author":"Sandza","year":"1977","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B49","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1055\/s-0034-1371697","article-title":"Are aortic valve reoperations after primary replacement with stentless heart valve prostheses more demanding than after stented biological prostheses?","volume":"62","author":"Boning","year":"2014","journal-title":"Thorac Cardiovasc Surg"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.athoracsur.2010.12.053","article-title":"Redo aortic valve surgery: early and late outcomes","volume":"91","author":"Leontyev","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"B51","doi-asserted-by":"publisher","first-page":"E170","DOI":"10.1532\/HSF98.20041005","article-title":"The risks and benefits of reoperative aortic valve replacement","volume":"7","author":"Gaudiani","year":"2004","journal-title":"Heart Surg Forum"},{"key":"B52","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1111\/jocs.13944","article-title":"Redo mitral valve surgery following prior mitral valve repair","volume":"33","author":"Kilic","year":"2018","journal-title":"J Card Surg"},{"key":"B53","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.jtcvs.2018.03.126","article-title":"Outcomes of repeat mitral valve replacement in patients with prior mitral surgery: a benchmark for transcatheter approaches","volume":"156","author":"Ejiofor","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B54","doi-asserted-by":"publisher","first-page":"728577","DOI":"10.3389\/fcvm.2021.728577","article-title":"Long-term stability and biocompatibility of pericardial bioprosthetic heart valves","volume":"8","author":"Williams","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1093\/ejcts\/ezaa257","article-title":"Decellularization and engineered crosslinking: a promising dual approach towards bioprosthetic heart valve longevity","volume":"58","author":"Human","year":"2020","journal-title":"Eur J Cardiothorac Surg"},{"key":"B56","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3978\/j.issn.2305-5839.2015.08.18","article-title":"Are anticoagulant independent mechanical valves within reach-fast prototype fabrication and in vitro testing of innovative bi-leaflet valve models","volume":"3","author":"Scotten","year":"2015","journal-title":"Ann Transl Med"},{"key":"B57","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.xjon.2021.05.011","article-title":"Aortic valve replacement in sheep with a novel trileaflet mechanical heart valve prosthesis without anticoagulation","volume":"7","author":"Schaller","year":"2021","journal-title":"JTCVS Open"},{"key":"B58","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.biomaterials.2014.09.013","article-title":"Polymeric heart valves for surgical implantation, catheter-based technologies and heart assist devices","volume":"36","author":"Bezuidenhout","year":"2015","journal-title":"Biomaterials"},{"key":"B59","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.matt.2019.05.013","article-title":"Bioinspired heart valve prosthesis made by silicone additive manufacturing","volume":"1","author":"Coulter","year":"2019","journal-title":"Matter"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezac115","article-title":"Immunoreaction to xenogenic tissue in cardiac surgery: alpha-gal and beyond","volume":"62","author":"Calafiore","year":"2022","journal-title":"Eur J Cardiothorac Surg"},{"key":"B61","first-page":"460","article-title":"The possible role of immune responses in bioprosthetic heart valve failure","volume":"10","author":"Human","year":"2001","journal-title":"J Heart Valve Dis"},{"key":"B62","doi-asserted-by":"publisher","first-page":"S385","DOI":"10.1016\/s0003-4975(01)02492-4","article-title":"Characterization of the immune response to valve bioprostheses and its role in primary tissue failure","volume":"71","author":"Human","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"B63","doi-asserted-by":"publisher","first-page":"791949","DOI":"10.3389\/fcvm.2022.791949","article-title":"The technological basis of a balloon-expandable TAVR system: non-occlusive deployment, anchorage in the absence of calcification and polymer leaflets","volume":"9","author":"Appa","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B64","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1093\/ejcts\/ezw050","article-title":"Decellularized fresh homografts for pulmonary valve replacement: a decade of clinical experience","volume":"50","author":"Sarikouch","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"B65","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/ejcts\/ezw013","article-title":"Decellularized aortic homografts for aortic valve and aorta ascendens replacement","volume":"50","author":"Tudorache","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"B66","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ejcts.2010.01.044","article-title":"Early failure of xenogenous de-cellularised pulmonary valve conduits\u2014a word of caution!","volume":"38","author":"Ruffer","year":"2010","journal-title":"Eur J Cardiothorac Surg"},{"key":"B67","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1093\/ejcts\/ezy377","article-title":"Long-term results after the ross procedure with the decellularized autotissue matrix P(R) bioprosthesis used for pulmonary valve replacement","volume":"55","author":"Christ","year":"2019","journal-title":"Eur J Cardiothorac Surg"},{"key":"B68","doi-asserted-by":"publisher","first-page":"760635","DOI":"10.3389\/fcvm.2021.760635","article-title":"Residual bioprosthetic valve immunogenicity: forgotten, not lost","volume":"8","author":"Human","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2023.1210098","article-title":"Correlations between the alpha-gal antigen, antibody response and calcification of cardiac valve bioprostheses: experimental evidence obtained using an alpha-gal knockout mouse animal model","volume":"14","author":"Naso","year":"2023","journal-title":"Front Immunol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1137827","DOI":"10.3389\/fcvm.2023.1137827","article-title":"Polymeric prosthetic heart valves: a review of current technologies and future directions","volume":"10","author":"Singh","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1161\/CIRCULATIONAHA.116.026714","article-title":"Edoxaban for the prevention of thromboembolism in patients with atrial fibrillation and bioprosthetic valves","volume":"135","author":"Carnicelli","year":"2017","journal-title":"Circulation"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezac286","article-title":"Surgical aortic valve replacement in patients aged 50\u201269 years-insights from the German Aortic Valve Registry (GARY)","volume":"62","author":"Vogt","year":"2022","journal-title":"Eur J Cardiothorac Surg"},{"key":"B73","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.jacc.2021.11.057","article-title":"Propensity-matched comparison of the ross procedure and prosthetic aortic valve replacement in adults","volume":"79","author":"El-Hamamsy","year":"2022","journal-title":"J Am Coll Cardiol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1347838\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T00:04:09Z","timestamp":1707437049000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1347838\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,9]]},"references-count":73,"alternative-id":["10.3389\/fcvm.2024.1347838"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2024.1347838","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,9]]},"article-number":"1347838"}}